{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:48:04Z","timestamp":1761976084131,"version":"3.37.3"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,3,20]],"date-time":"2024-03-20T00:00:00Z","timestamp":1710892800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,3,20]],"date-time":"2024-03-20T00:00:00Z","timestamp":1710892800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100008235","name":"Peking Union Medical College Hospital","doi-asserted-by":"publisher","award":["2022-PUMCH-A-036"],"award-info":[{"award-number":["2022-PUMCH-A-036"]}],"id":[{"id":"10.13039\/501100008235","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Endometrial cancer is a prevalent gynecologic malignancy found in postmenopausal women. However, in the last two decades, the incidence of early-stage has doubled in women under 40 years old. This study aimed to investigate the clinical and pathological characteristics and adjuvant therapeutic modalities of both young and not -young patients with early-stage endometrial cancer in China\u2019s real world.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This retrospective study analyzed patients with early-stage endometrial cancer at 13 medical institutions in China from 1999 to 2015. The patients were divided into two groups: young (\u2264\u200945 years old) and non-young (&gt;\u200945 years old). Statistical comparisons were conducted between the two groups for clinical characteristics, pathological features, and survival. The study also identified factors that affect local recurrence-free survival (LRFS) using Cox proportional risk regression analysis. Propensity score matching (1:1) was used to compare the effects of local control between vaginal brachytherapy (VBT) alone and pelvic external beam radiotherapy (EBRT)\u2009\u00b1\u2009VBT.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The study involved 1,280 patients, 150 of whom were 45 years old or younger. The young group exhibited a significantly higher proportion of stage II, low-risk, lower uterine segment infiltration (LUSI), and cervical invasion compared to the non-young group. Additionally, the young patients had significantly larger maximum tumor diameters. The young group also had a significantly higher five-year overall survival (OS) and a five-year LRFS. Age is an independent risk factor for LRFS. There was no significant difference in LRFS between young patients with intermediate- to high-risk early-stage endometrial cancer who received EBRT\u2009\u00b1\u2009VBT and those who received VBT alone.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>In the present study, young patients had better characteristics than the non-young group, while they exhibited higher levels of aggressiveness in certain aspects. The LRFS and OS outcomes were better in young patients. Age is an independent risk factor for LRFS. Additionally, VBT alone may be a suitable option for patients under 45 years of age with intermediate- to high-risk early-stage endometrial cancer, as it reduces the risk of toxic reactions and future second cancers while maintaining similar local control as EBRT.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12885-024-12090-3","type":"journal-article","created":{"date-parts":[[2024,3,20]],"date-time":"2024-03-20T20:02:17Z","timestamp":1710964937000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Clinical characteristics and radiation therapy modality of younger patients with early-stage endometrial cancer, a multicenter study in China\u2019s real world"],"prefix":"10.1186","volume":"24","author":[{"given":"Kun","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiejun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianli","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoge","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fengjv","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaomei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sha","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhanshu","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ke","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fuquan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaorong","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lichun","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lijuan","family":"Zou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,3,20]]},"reference":[{"issue":"2","key":"12090_CR1","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.ygyno.2021.01.036","volume":"161","author":"B Gu","year":"2021","unstructured":"Gu B, Shang X, Yan M, Li X, Wang W, Wang Q, et al. Variations in incidence and mortality rates of endometrial cancer at the global, regional, and national levels, 1990\u20132019. Gynecol Oncol. 2021;161(2):573\u201380.","journal-title":"Gynecol Oncol"},{"issue":"3","key":"12090_CR2","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer statistics 2020: GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"12090_CR3","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/j.ajog.2020.12.1213","volume":"224","author":"K Matsuo","year":"2021","unstructured":"Matsuo K, Mandelbaum RS, Matsuzaki S, Klar M, Roman LD, Wright JD. Ovarian conservation for young women with early-stage, low-grade endometrial cancer: a 2-step schema. Am J Obstet Gynecol. 2021;224(6):574\u201384.","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"12090_CR4","doi-asserted-by":"publisher","first-page":"275","DOI":"10.5603\/GP.a2022.0106","volume":"94","author":"A Yordanov","year":"2023","unstructured":"Yordanov A, Kostov S, Kornovski Y, Slavchev S, Ivanova Y, Calleja-Agius J, et al. Endometrial carcinoma in patients under 40 years of age: insights from the Bulgarian Cancer Registry. Ginekol Pol. 2023;94(4):275\u201382.","journal-title":"Ginekol Pol"},{"issue":"2","key":"12090_CR5","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.ygyno.2011.09.027","volume":"124","author":"A Semaan","year":"2012","unstructured":"Semaan A, Ali-Fehmi R, Munkarah AR, Bandyopadhyay S, Morris RT, Rizk S, et al. Clinical\/pathologic features and patient outcome in early onset endometrial carcinoma: a population based analysis and an institutional perspective from the Detroit metropolitan area, Michigan. Gynecol Oncol. 2012;124(2):265\u20139.","journal-title":"Gynecol Oncol"},{"issue":"5","key":"12090_CR6","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1016\/j.ajog.2005.05.003","volume":"193","author":"GP Pellerin","year":"2005","unstructured":"Pellerin GP, Finan MA. Endometrial cancer in women 45 years of age or younger: a clinicopathological analysis. Am J Obstet Gynecol. 2005;193(5):1640\u20134.","journal-title":"Am J Obstet Gynecol"},{"issue":"15","key":"12090_CR7","doi-asserted-by":"publisher","first-page":"19561","DOI":"10.18632\/aging.203367","volume":"13","author":"S Sun","year":"2021","unstructured":"Sun S, Zou L, Wang T, Liu Z, He J, Sun X, et al. Effect of age as a continuous variable in early-stage endometrial carcinoma: a multi-institutional analysis in China. Aging. 2021;13(15):19561\u201374.","journal-title":"Aging"},{"issue":"1","key":"12090_CR8","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1006\/gyno.2000.5917","volume":"79","author":"AJ Mundt","year":"2000","unstructured":"Mundt AJ, Waggoner S, Yamada D, Rotmensch J, Connell PP. Age as a prognostic factor for recurrence in patients with endometrial carcinoma. Gynecol Oncol. 2000;79(1):79\u201385.","journal-title":"Gynecol Oncol"},{"key":"12090_CR9","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.radonc.2020.11.018","volume":"154","author":"N Concin","year":"2021","unstructured":"Concin N, Matias-Guiu X, Vergote I, Cibula D, Mirza MR, Marnitz S, et al. ESGO\/ESTRO\/ESP guidelines for the management of patients with endometrial carcinoma. Radiother Oncol. 2021;154:327\u201353.","journal-title":"Radiother Oncol"},{"issue":"21","key":"12090_CR10","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1093\/jnci\/djs374","volume":"104","author":"A Kong","year":"2012","unstructured":"Kong A, Johnson N, Kitchener HC, Lawrie TA. Adjuvant Radiotherapy for Stage I endometrial Cancer: an Updated Cochrane Systematic Review and Meta-analysis. JNCI J Natl Cancer Inst. 2012;104(21):1625\u201334.","journal-title":"JNCI J Natl Cancer Inst"},{"issue":"9717","key":"12090_CR11","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/S0140-6736(09)62163-2","volume":"375","author":"R Nout","year":"2010","unstructured":"Nout R, Smit V, Putter H, J\u00fcrgenliemk-Schulz I, Jobsen J, Lutgens L, et al. Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial. Lancet. 2010;375(9717):816\u201323.","journal-title":"Lancet"},{"issue":"3","key":"12090_CR12","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.ygyno.2017.12.032","volume":"148","author":"B Mukerji","year":"2018","unstructured":"Mukerji B, Baptiste C, Chen L, Tergas AI, Hou JY, Ananth CV, et al. Racial disparities in young women with endometrial cancer. Gynecol Oncol. 2018;148(3):527\u201334.","journal-title":"Gynecol Oncol"},{"issue":"5","key":"12090_CR13","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1097\/00000421-200010000-00009","volume":"23","author":"BN Tran","year":"2000","unstructured":"Tran BN, Connell PP, Waggoner S, Rotmensch J, Mundt AJ. Characteristics and outcome of Endometrial Carcinoma patients Age 45 years and younger. Am J Clin Oncol Cancer Clin Trials. 2000;23(5):476\u201380.","journal-title":"Am J Clin Oncol Cancer Clin Trials"},{"issue":"3","key":"12090_CR14","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/S0029-7844(97)00668-6","volume":"91","author":"E Evansmetcalf","year":"1998","unstructured":"Evansmetcalf E. Profile of women 45 years of age and younger with endometrial cancer*1. Obstet Gynecol. 1998;91(3):349\u201354.","journal-title":"Obstet Gynecol"},{"issue":"2","key":"12090_CR15","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1006\/gyno.2001.6434","volume":"83","author":"LR Duska","year":"2001","unstructured":"Duska LR, Garrett A, Rueda BR, Haas J, Chang Y, Fuller AF. Endometrial Cancer in women 40 years old or younger. Gynecol Oncol. 2001;83(2):388\u201393.","journal-title":"Gynecol Oncol"},{"issue":"6","key":"12090_CR16","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1097\/IGC.0000000000000193","volume":"24","author":"HY Lau","year":"2014","unstructured":"Lau HY, Chen YJ, Yen MS, Chao KC, Chen RF, Yeh SO, et al. Clinicopathological features and survival in Young Taiwanese Women with Endometrial Carcinoma. Int J Gynecol Cancer. 2014;24(6):1015\u201320.","journal-title":"Int J Gynecol Cancer"},{"issue":"4","key":"12090_CR17","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s00432-002-0327-4","volume":"128","author":"M Saegusa","year":"2002","unstructured":"Saegusa M, Machida D, Okayasu I. Age-dependent differences in tumor cell polarity in endometrial carcinomas. J Cancer Res Clin Oncol. 2002;128(4):205\u201313.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"5","key":"12090_CR18","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1136\/ijgc-2019-001105","volume":"30","author":"J Son","year":"2020","unstructured":"Son J, Carr C, Yao M, Radeva M, Priyadarshini A, Marquard J, et al. Endometrial cancer in young women: prognostic factors and treatment outcomes in women aged\u2009\u2264\u200940 years. Int J Gynecol Cancer. 2020;30(5):631\u20139.","journal-title":"Int J Gynecol Cancer"},{"key":"12090_CR19","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.ijsu.2017.06.083","volume":"44","author":"A Biler","year":"2017","unstructured":"Biler A, Solmaz U, Erkilinc S, Gokcu M, Bagci M, Temel O, et al. Analysis of endometrial carcinoma in young women at a high-volume cancer center. Int J Surg. 2017;44:185\u201390.","journal-title":"Int J Surg"},{"key":"12090_CR20","doi-asserted-by":"crossref","unstructured":"Benedetti Panici P, Basile S, Salerno MG, Di Donato V, Marchetti C, Perniola G et al. Secondary analyses from a randomized clinical trial: age as the key prognostic factor in endometrial carcinoma. Am J Obstet Gynecol. 2014;210(4):363.e1-363.e10.","DOI":"10.1016\/j.ajog.2013.12.025"},{"issue":"2","key":"12090_CR21","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.ygyno.2010.10.038","volume":"120","author":"ND Fleming","year":"2011","unstructured":"Fleming ND, Lentz SE, Cass I, Li AJ, Karlan BY, Walsh CS. Is older age a poor prognostic factor in stage I and II endometrioid endometrial adenocarcinoma? Gynecol Oncol. 2011;120(2):189\u201392.","journal-title":"Gynecol Oncol"},{"issue":"3","key":"12090_CR22","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1111\/aogs.14015","volume":"100","author":"N Hag-Yahia","year":"2021","unstructured":"Hag-Yahia N, Gemer O, Eitan R, Raban O, Vaknin Z, Levy T, et al. Age is an independent predictor of outcome in endometrial cancer patients: an Israeli Gynecology Oncology Group cohort study. Acta Obstet Gynecol Scand. 2021;100(3):444\u201352.","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"1","key":"12090_CR23","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.ygyno.2015.04.010","volume":"138","author":"MM AlHilli","year":"2015","unstructured":"AlHilli MM, Bakkum-Gamez JN, Mariani A, Weaver AL, McGree ME, Keeney GL, et al. Risk-adjusted outcomes in elderly endometrial cancer patients: implications of the contrasting impact of age on progression-free and cause-specific survival. Gynecol Oncol. 2015;138(1):133\u201340.","journal-title":"Gynecol Oncol"},{"issue":"3","key":"12090_CR24","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1097\/IGC.0000000000000890","volume":"27","author":"L Haley","year":"2017","unstructured":"Haley L, Burmeister C, Buekers T, Elshaikh MA. Is older Age a real adverse prognostic factor in Women with Early-Stage Endometrial Carcinoma? A matched analysis. Int J Gynecol Cancer. 2017;27(3):479\u201385.","journal-title":"Int J Gynecol Cancer"},{"issue":"8","key":"12090_CR25","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1007\/s00432-018-2659-8","volume":"144","author":"P Hass","year":"2018","unstructured":"Hass P, Seinsch S, Eggemann H, Ignatov T, Seitz S, Ignatov A. Vaginal brachytherapy for endometrial cancer. J Cancer Res Clin Oncol. 2018;144(8):1523\u201330.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"3","key":"12090_CR26","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.prro.2014.01.003","volume":"4","author":"A Klopp","year":"2014","unstructured":"Klopp A, Smith BD, Alektiar K, Cabrera A, Damato AL, Erickson B, et al. The role of postoperative radiation therapy for endometrial cancer: executive summary of an American Society for Radiation Oncology evidence-based guideline. Pract Radiat Oncol. 2014;4(3):137\u201344.","journal-title":"Pract Radiat Oncol"},{"issue":"4","key":"12090_CR27","doi-asserted-by":"publisher","first-page":"e631","DOI":"10.1016\/j.ijrobp.2011.04.013","volume":"81","author":"CL Creutzberg","year":"2011","unstructured":"Creutzberg CL, Nout RA, Lybeert MLM, W\u00e1rl\u00e1m-Rodenhuis CC, Jobsen JJ, Mens JWM, et al. Fifteen-year Radiotherapy outcomes of the Randomized PORTEC-1 Trial for Endometrial Carcinoma. Int J Radiat Oncol. 2011;81(4):e631\u20138.","journal-title":"Int J Radiat Oncol"},{"issue":"31","key":"12090_CR28","doi-asserted-by":"publisher","first-page":"3951","DOI":"10.1200\/JCO.2013.48.8023","volume":"31","author":"M Onsrud","year":"2013","unstructured":"Onsrud M, Cvancarova M, Hellebust TP, Trop\u00e9 CG, Kristensen GB, Lindemann K. Long-term outcomes after Pelvic Radiation for Early-Stage Endometrial Cancer. J Clin Oncol. 2013;31(31):3951\u20136.","journal-title":"J Clin Oncol"},{"issue":"9","key":"12090_CR29","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1038\/s41416-018-0310-8","volume":"119","author":"BG Wortman","year":"2018","unstructured":"for the PORTEC Study Group, Wortman BG, Creutzberg CL, Putter H, J\u00fcrgenliemk-Schulz IM, Jobsen JJ, et al. Ten-year results of the PORTEC-2 trial for high-intermediate risk endometrial carcinoma: improving patient selection for adjuvant therapy. Br J Cancer. 2018;119(9):1067\u201374.","journal-title":"Br J Cancer"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-024-12090-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-024-12090-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-024-12090-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,20]],"date-time":"2024-03-20T20:02:21Z","timestamp":1710964941000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-024-12090-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,20]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["12090"],"URL":"https:\/\/doi.org\/10.1186\/s12885-024-12090-3","relation":{},"ISSN":["1471-2407"],"issn-type":[{"type":"electronic","value":"1471-2407"}],"subject":[],"published":{"date-parts":[[2024,3,20]]},"assertion":[{"value":"10 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Clinical samples were collected under protocols approved by the Institutional Review Board of Peking Union Medical College Hospital (N0. S-K139) on Oct.24, 2016. We confirm that the Institutional Review Board of Peking Union Medical College Hospital waived the need for obtaining informed consent given the retrospective nature of the study. We confirm that all methods were performed following the relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"360"}}